tiprankstipranks
Trending News
More News >
Vertex Pharmaceuticals Inc. (VRTX)
NASDAQ:VRTX

Compare Vertex Pharmaceuticals (VRTX) vs. Competitors

Compare
6,641 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Vertex Pharmaceuticals
$462.49
$117.49B
29.32
-11.84%
22 Buy
3 Hold
0 Sell
Strong Buy
Alnylam Pharma
$320.42
$42.50B
166.04
28.86%
16 Buy
3 Hold
0 Sell
Strong Buy
Incyte
$94.22
$18.75B
14.98
53.73%
8 Buy
8 Hold
1 Sell
Moderate Buy
Regeneron
$756.91
$80.23B
17.92
11.90%
18 Buy
5 Hold
0 Sell
Strong Buy
Argenx Se
$706.03
$43.96B
39.77
12.04%
17 Buy
2 Hold
0 Sell
Strong Buy
BioNTech SE
$94.86
$23.84B
-9.05%
13 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
VRTX
Vertex Pharmaceuticals
451.59
-60.93
-11.89%
ALNY
Alnylam Pharma
314.80
61.36
24.21%
INCY
Incyte
92.24
31.90
52.87%
REGN
Regeneron
744.12
75.41
11.28%
ARGX
Argenx Se
684.77
64.80
10.45%
BNTX
BioNTech SE
90.00
-9.27
-9.34%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts